Form 8-K - Current report:
SEC Accession No. 0001640334-24-001796
Filing Date
2024-11-27
Accepted
2024-11-26 18:00:09
Documents
17
Period of Report
2024-11-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bdpt_8k.htm   iXBRL 8-K 20513
2 PRESS RELEASE bdpt_ex991.htm EX-99.1 5578
8 bdpt_8kimg5.jpg GRAPHIC 5415
  Complete submission text file 0001640334-24-001796.txt   156461

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20241126.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20241126_lab.xml EX-101.LAB 13171
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20241126_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20241126_pre.xml EX-101.PRE 8249
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20241126_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_8k_htm.xml XML 3537
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54949 | Film No.: 241505726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)